alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# Sydenham Chorea

## What is Sydenham chorea?

Sydenham chorea (SC) is a neurological disorder that happens in childhood. It is caused by the same bacteria that causes rheumatic fever. Rheumatic fever is a disease that may develop after an infection with group A streptococcus bacteria, such as strep throat or scarlet fever, and can cause severe illness in the heart, joints, skin, and brain. 

SC affects girls more often than boys, and usually happens between ages 5 and 15. Symptoms can happen slowly over time or all at once, and may include:

                    - Clumsy movements
                    - Muscle weakness
                    - Stumbling or falling down
                    - Not being able to speak clearly

                    - Having a hard time focusing or writing 
                    - Having a hard time keeping emotions stable

Some kids will have a sore throat a few weeks before their symptoms start. SC can also happen up to six months after a child has a fever, or the strep throat infection goes away. 

There is no treatment for SC. People that have mild symptoms may feel better with bed rest. Other individuals may need medications to help. 

Most children will completely heal from SC. Very few will have symptoms that last for a long time. Symptoms usually last for three to six weeks, but sometimes they can last for months. Some children with SC may have another episode of symptoms after the first illness. This usually happens one and a half to two and a half years later. 

file-medical

## How can I or a loved one improve care for people with Sydenham chorea?

Consider participating in a clinical trial so clinicians and scientists can learn more about SC and related disorders. Clinical research uses human volunteers to help researchers learn more about a disorder and perhaps find better ways to safely detect, treat, or prevent disease. 

All types of volunteers are needed—those who are healthy or may have an illness or disease—of all different ages, sexes, races, and ethnicities to ensure that study results apply to as many people as possible, and that treatments will be safe and effective for everyone who will use them. 

For information about participating in clinical research visit NIH Clinical Research Trials and You. Learn about clinical trials currently looking for people with SC at Clinicaltrials.gov.
> Where can I find more information about Sydenham chorea?
Information may be available from the following organizations:

Medline Plus

National Organization for Rare Diseases (NORD)Phone: 203-744-0100 or 800-999-6673; 844-259-7178 Spanish

book-open
**Certification      Pursuant to 18 U.S.C. Section 1350, As Adopted**

**Pursuant      to Section 906 of The Sarbanes-Oxley Act of 2002**

| (1) | the                Report on Form 10-KSB of the Company for the fiscal years ended December                31, 2003, and December 31, 2004, and the quarters ended March 31,                2003,                June 30, 2003, September 30, 2003, March 31, 2004, June 30, 2004,                and                September 30, 2004 (the “Report”) fully complies with the requirements of                Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934 (15                U.S.C.                78m or 78o(d)); and |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (2) | the                information contained in the Report fairly presents, in all material                respects, the financial condition and results of operations of the                Company. |
|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

----
EXHIBIT 99.1

Certification  Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002  (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18,United States Code)

Pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), each of the
undersigned officers of Apogee Technology, Inc. a Delaware corporation (the "Company"), does hereby certify, to such officer's knowledge, that:

The
Quarterly Report on Form 10-Q for the quarter ended June 30, 2002 (the "Form 10-Q") of the Company fully complies with the requirements
of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly represents, in all material respects, the financial
condition and results of operations of the Company.

|Dated: August 14, 2002 |  | /s/HERBERT M. STEIN
|---------------------- |  | -------------------
|                       |  | Name:              
|                       |  | Title:             
|Dated: August 14, 2002 |  | /s/DAVID SPIEGEL   
|                       |  | Name:              
|                       |  | Title:             

The
foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350,
Chapter 63 of Title 18, United States Code) and is not being filed as part of a separate disclosure document.

---

QuickLinks
WRIT NO S

. W06

- 00445

- K(B), W06

- 00448

- K ( B) , W06

- 00450

- K(B) and

W06

- 00453

- K(B)

In the

Texas Court of Criminal Appeals

At Austin

From the CDC No. 4

Dallas C o unty, Texas

EX PARTE

RAUL DAVID JACKSON,

Applicant,

11.07 Writ

MOTION FOR EXTENSION OF TIME TO TURN IN

FINDING OF FACTS AND CONLUSIONS OF LAW

Bruce Kaye

TBN. 00784374

2309 Boll St.

Dallas, TX 75204

(214) 722

- 7438

Appointed Writ Master, CDC 4

TO THE HONORABLE JUDGES OF THE COURT OF CRIMINAL APPEALS: WR-73,697-06,07,08,09

COURT OF CRIMINAL APPEALS

AUSTIN, TEXAS

Transmitted 5/19/2015 2:50:52 PM

Accepted 5/22/2015 8:26:08 AM

ABEL ACOSTA

CLERKI.

On or about November 26, 2014, the undersigned was appointed as Writ Master by

the Honorable Judge Dominique Collins, Criminal District Court No. 4, Dallas County,

T e xas. The Court ’ s Finding of Fact and Conclusions of Law are due on or about May 20

,

2015.

II.

This issues to be resolved are as follows:

a. Is App l icant ’ s judgment and sentence void;

b. Does Applicant ’ s se n t e n ce violate double jeopardy;

c. Was Applicant ’ s plea involuntary; and

d. Did Applicant receive ineffective assistance of trial and appellate counsel.

II I

.

The undersigned Writ Master has been involved in numerous Appellate matters for

both st ate and federal cases. One case was a Capital Murder (non death penalty) which

produced a 100 page brief. Currently, there are three (3) app eals all due within the next 30

days and two (2) trials also scheduled in the same time frame. An additional 90 days is

required in order to properly read Applicant ’ s paperwork, review the State ’ s response,

research the issues and the reafter prepare the Finding of Fact and C o nclusions of Law for

the Court.WHEREFORE,	 PREMISES	 CONSIDERED ,	 the undersigned Writ	 Master	 prays

this C ourt	 grant	 his	 Motion	 for	 Extens ion	 of Time	 to Turn	 in	 Finding	 of	 Facts	 and

Conclusions	of	Law.

Respectfully	submitted,



### /s/ Bruce Kaye

BRUCE C. KAYE

By: Bruce Kaye

TBN 00784374

Appointed Writ Master

2309 Boll. St.

Dallas, TX 75204

( 214) 722

- 7438

(866) 649

- 8757 facsimile

Bruce@brucekaye.com

### CERTIFICATE OF SERVICE

I hereby certify that a true and correct copy of this document

was tendered to Dallas County District Clerk ’ s Office

, on the 20 th 

### Day of

May

, 2015, in accordance with the Texas Rules of Appellate Procedure.

/s/ Bruce Kaye

BRUCE C. KAYE

,
<PAGE>   1
 
                                                                      EXHIBIT 11
 
                             BAY STATE GAS COMPANY
 
                STATEMENT RE:  COMPUTATION OF PER SHARE EARNINGS
 
<TABLE>
<CAPTION>
                                                 1997       1996       1995       1994       1993
                                                ------     ------     ------     ------     ------
<S>                                             <C>        <C>        <C>        <C>        <C>
Primary earnings per share....................  $ 1.92     $ 2.00     $ 1.71     $ 1.85     $ 1.75

Dilutive effect of outstanding options to
  purchase common stock.......................   (0.01)     (0.02)     (0.01)     (0.02)     (0.03)
                                                ------     ------     ------     ------     ------
Fully diluted earnings per share..............  $ 1.91     $ 1.98     $ 1.70     $ 1.83     $ 1.72
                                                ======     ======     ======     ======     ======
</TABLE>
 

                                       39
Mr. Tom Logar, President 

GlobalNet Management LC 

80 Celestial Way #IIO 

June Beach FL 33408 

Re: InterBlock roulette and dice games 

Dear Mr. Logar: 

This is in response to your January 10, 2003, request for classification of Interblock's 

various roulette and dice games. Please accept my sincere apologies for the length of 

time that has passed between your inquiry and this answer. 

The materials you provided depict single- and double-zero roulette, implemented with 

an automated roulette wheel and individual player stations where players insert money, 

make their wagers, and receive their winnings. The materials also depict similarly 

automated implementations of Sic Bo and two related dice games. I agree with your 

assessment of the games as Class 111. 

The games fall within the definition of Class 111, a catch-all category encompassing all 

forms of gaming that are not Class I or Class 11.25 U.S.C. 5 2703(8). The games are not 

Class I because they are not social games played "solely for prizes of minimal valuen or 

"traditional form[s] of Indian gamingn played "as a part of, or in connection with" tribal 

ceremonies or celebrations. 25 U.S.C. 5 2703(6). Likewise, they are not Class 11, which 

includes only bingo, non-house banked card games and, provided that they are played 

in the same location as bingo, lotto, pull tabs, tip jars, punch boards, instant bingo, and 

games similar to bingo. 25 U.S.C. 5 2703(7)(A). 

That said, you also ask whether the games are slot machines or table games, and, if they 

are slot machines, whether each assembly is a single machine or whether each player 

station is an independent slot machine. These are questions upon which I offer no 

opinion. 

Such questions call for the interpretation of individual tribal-state compacts - e.g. those 

that place limitations on the number of slot machines allowed in one tribal gaming 

facility or those that call for payment of gaming revenue from slot machines but not 

from table games. As a general matter, we leave interpretation of compacts to the States 

IIIIIW and Tribes in the first instance. Only if necessary do we venture into such matters. 

NATIONAL HEADQUARTERS 1441 L St. NW, Suite 9100, Washington. DC 20005 Tel: 202.632.7003 Fax: 202.632.7066 www.nlcc.cov 

REGIONAL OFFICES Portland. OR; Sacramento, CA; Phoenix. AZ; St. Paul. MN;Tulsa. OK 
If you have any questions about this advisory opinion, please do not hesitate to contact 

Michael Gross, Staff Attorney, at 202-632-7003. 

ICI(*(IJ 

Sincerely, 

Penny J. Coleman 

Acting General Counsel
<TABLE> <S> <C>

<ARTICLE> 7
<CIK> 0000823533
<NAME> FORTIS BENEFITS INSURANCE COMPANY
<MULTIPLIER> 1000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               JUN-30-1998
<DEBT-HELD-FOR-SALE>                         2,343,094
<DEBT-CARRYING-VALUE>                                0
<DEBT-MARKET-VALUE>                                  0
<EQUITIES>                                     117,324
<MORTGAGE>                                     614,905
<REAL-ESTATE>                                   52,022
<TOTAL-INVEST>                               3,351,446         
<CASH>                                         (31,387) 
<RECOVER-REINSURE>                              18,209
<DEFERRED-ACQUISITION>                         297,990
<TOTAL-ASSETS>                               7,314,852
<POLICY-LOSSES>                              2,527,525
<UNEARNED-PREMIUMS>                             11,575
<POLICY-OTHER>                                 251,479
<POLICY-HOLDER-FUNDS>                            8,446
<NOTES-PAYABLE>                                      0
<COMMON>                                         5,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                     905,307
<TOTAL-LIABILITY-AND-EQUITY>                 7,314,852
<PREMIUMS>                                     634,996
<INVESTMENT-INCOME>                            119,113
<INVESTMENT-GAINS>                              41,019 
<OTHER-INCOME>                                  22,532
<BENEFITS>                                     526,777
<UNDERWRITING-AMORTIZATION>                     25,896
<UNDERWRITING-OTHER>                           203,995
<INCOME-PRETAX>                                 58,958 
<INCOME-TAX>                                    20,653 
<INCOME-CONTINUING>                             38,305 
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    38,305 
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
<RESERVE-OPEN>                                 988,036
<PROVISION-CURRENT>                                  0
<PROVISION-PRIOR>                                    0
<PAYMENTS-CURRENT>                                   0
<PAYMENTS-PRIOR>                                     0
<RESERVE-CLOSE>                                      0
<CUMULATIVE-DEFICIENCY>                              0
        

</TABLE>
IN THE DISTRICT COURT OF APPEAL OF THE STATE OF FLORIDA

FIFTH DISTRICT

RONALD CURRY, 

Appellant, 

v. Case No. 5D22-2008

LT Case No. 2010-CF-009187-D-O

STATE OF FLORIDA, 

Appellee. 

________________________________/

Opinion filed October 21, 2022

3.800 Appeal from the Circuit Court

for Orange County, 

Luis Fernando Calderon, Judge. 

Ronald Curry, Orlando, pro se.

Ashley Moody, Attorney General,

Tallahassee, and L. Charlene 

Matthews, Assistant Attorney General,

Daytona Beach, for Appellee.

PER CURIAM.

The appellant, Ronald Curry, continues to raise the same claim of 

error, which has been considered on the merits, disposed of by the trial court, 

and reviewed in this court on multiple occasions. The continuous attempts 
2 

by this appellant to revisit this issue are frivolous and an abuse of this court's 

process. 

As such, the appellant is cautioned that any further pro se pleadings 

filed in this court asserting the claim raised in this case and regarding the 

sentence imposed in Orange County Circuit Case No. 2010-CF-009187-DO may result in Spencer sanctions being imposed. See State v. Spencer, 

751 So. 2d 47 (Fla. 1999).

APPELLANT WARNED. 

COHEN, SASSO and WOZNIAK, JJ., concur.
- 052808 Tulalip Ordinance Approval Letter
- 042408 Tulalip Ordinance 55
|    |                                                                               |
|----|-------------------------------------------------------------------------------|
| 1. | I have reviewed this Annual Report on Form 10-K/A of Black Hills Power, Inc.; |

|    |                                                                                                                                                                                                                                                                                                                |
|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; and |

|    |                                                                                                                                                                                                                                                                                         |
|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report. |

|                     |
|---------------------|
|                     |  |
| Date: April 2, 2012 |   |
|                |   |
|                | /S/ DAVID R. EMERY |
|                | David R. Emery |
|                | Chairman and Chief Executive Officer |
STOCK REDEMPTIONAGREEMENT 

        ThisStock Redemption Agreement (the “Agreement”) is made as of the 13th day ofNovember, 2006, by and between MTS Medication Technologies, Inc., a Delaware corporation(f/k/a Medical Technology Systems, Inc.) (the “Corporation”), and Eureka I,L.P., a Delaware limited partnership (the “Selling Stockholder”). 

Background 

        TheSelling Stockholder owns two thousand shares of Series A Convertible ParticipatingPreferred Stock of the Corporation (the “Subject Shares”). The SellingStockholder desires to sell and transfer to the Corporation, and the Corporation desiresto redeem and acquire from the Selling Stockholder, in exchange for the considerationdescribed in this Agreement, the Subject Shares, pursuant to the terms and subject to theconditions set forth in this Agreement. In consideration of the mutual agreements,covenants and provisions set forth below, the parties to this Agreement agree forthemselves and their respective heirs, executors, administrators, successors and assigns,as follows: 

Terms 

ARTICLE I 

THE TRANSACTION 

    1.01        Redemptionof the Subject Shares. On the Closing Date (defined below), pursuant to the terms andsubject to the conditions contained in this Agreement, the Selling Stockholder shallsell, assign, transfer, convey and deliver to the Corporation, and the Corporation shallredeem, acquire and accept from the Selling Stockholder, all of the Selling Stockholder’sright, title and interest in and to the Subject Shares free and clear of all liens,pledges, claims, options, charges or encumbrances of any type, for the considerationspecified in Section 1.02 of this Agreement, to be paid as provided in Section 1.02 ofthis Agreement.  

    1.02        PurchasePrice. The aggregate purchase price for the Subject Shares shall be six million fourhundred eighty three thousand and forty six dollars ($6,483,046) (the “PurchasePrice). In addition, the Corporation shall pay a transfer fee in the amount of twentythousand dollars ($20,000) (the “Transaction Fee”) to the Selling Stockholder.The Purchase Price and the Transaction Fee shall be payable by the Corporation by wiretransfer at the Closing.  

    1.03        ClosingDate. The closing shall be held at the offices of Holland & Knight, LLP, Suite4100, 100 North Tampa Street, Tampa, Florida 33602 on or before December 29, 2006****(the“Closing” or the “Closing Date”). Either party (if such party is notthen in breach of this Agreement) may terminate this Agreement if the Closing has notoccurred by the close of business on December 29, 2006  

----
Exhibit 24


                                POWER OF ATTORNEY


       We,  the  undersigned  Directors  and  Officers  of The  Black  &  Decker
Corporation  (the  "Corporation"),   hereby  constitute  and  appoint  Nolan  D.
Archibald, Michael D. Mangan and Charles E. Fenton, and each of them, with power
of substitution,  our true and lawful  attorneys-in-fact with full power to sign
for us, in our names and in the capacities  indicated below,  the  Corporation's
Annual Report on Form 10-K for the year ended December 31, 2002, and any and all
amendments thereto.


/s/ NOLAN D. ARCHIBALD         Director, Chairman, President   February 13, 2003
----------------------------    and Chief Executive Officer
Nolan D. Archibald             (Principal Executive Officer)




----------------------------             Director              February 13, 2003
Norman R. Augustine


/s/ BARBARA L. BOWLES                    Director              February 13, 2003
----------------------------
Barbara L. Bowles


/s/ M. ANTHONY BURNS                     Director              February 13, 2003
----------------------------
M. Anthony Burns


/s/ MALCOLM CANDLISH                     Director              February 13, 2003
----------------------------
Malcolm Candlish


/s/ MANUEL A FERNANDEZ                   Director              February 13, 2003
----------------------------
Manuel A. Fernandez


/s/ BENJAMIN H. GRISWOLD, IV             Director              February 13, 2003
----------------------------
Benjamin H. Griswold, IV


/s/ ANTHONY LUISO                        Director              February 13, 2003
----------------------------
Anthony Luiso


/s/ MICHAEL D. MANGAN          Senior Vice President and       February 13, 2003
----------------------------   Chief Financial Officer
Michael D. Mangan              (Principal Financial Officer)


/s/ CHRISTINA M. MCMULLEN      Vice President and Controller   February 13, 2003
----------------------------   (Principal Accounting Officer)
Christina M. McMullen